CHINA TOPIX

11/24/2024 07:17:12 pm

Make CT Your Homepage

BLINCYTO

Amgen Announces BLINCYTO A Successful Drug For Leukemia

Amgen Announces BLINCYTO A Successful Drug For Leukemia In Phase 2 Trial

BLINCYTO, a drug for relapsed or refractory Philadelphia chromosome-positive (Ph+) B-cell precursor acute lymphoblastic leukemia, was found to be a great success in phase 2 trials, announced Amgen on Thursday, July 16.

Real Time Analytics